At the recent IAS 2017 conference, we got good news about the safety and efficacy of a long-acting antiretroviral injection and a drug in a new class of medications. Read More
In a study with more than 300 gay men with HIV, there were zero HIV transmissions to HIV-negative sex partners if people had undetectable viral loads. Read More
New research from #IAS2017 shows that the risk of cognitive impairment is reduced by 11% with every 10 mg/dL increase in HDL cholesterol. Read More
New research reveals who’s at higher risk of getting Kaposi sarcoma, and what people living with HIV can do to decrease their risk of getting this AIDS-associated cancer.
Researchers are investigating whether antibodies can be used to provide long-lasting protection from HIV. Get an explanation on how antibodies protect, and how far the science has progressed. Read More